Abstract
In this study, we prepared two different type complex groups. One of them is based on Schiff base (A1 , A2 and A3) Cd(II) complexes, another one is β-blockers (acebutolol (ACE), atenolol (ATE) and propranolol (PRO)) Cu(II) complexes. The ligands and their metal complexes were characterized by elemental analyses, mass spectra, 1H(13C) NMR spectra, FT-IR, UV-vis, conductivity measurements and thermal analysis studies. Protonation constants of the ligands and stability constants of their complexes were determined by potentiometric titration method at 25.00±0.02 oC under nitrogen atmosphere and ionic strength of 0.10 M sodium perchlorate. For the Schiff bases, the solvent was 50% DMSO – water; for the β-blockers, it was 50% methanol-water media. The effects of these properties on the observed inhibition of chemiluminescence and the analytical implications of the results are also discussed. Two sets of novel coordination compounds were found to inhibit the intense chemiluminescence reaction in DMSO solution between luminol and dioxygen in the presence of a strong base.
Keywords: Schiff base ligands, Complexes, β-blockers, Stability Constants, Potentiometric studies, Luminol chemiluminescence
Current Analytical Chemistry
Title: Investigations into the Inhibition of Luminol Chemiluminescence by some Novel Metal Complexes
Volume: 6 Issue: 2
Author(s): Aysegul Golcu, R. Alan Wheatley, Havva Demirelli, Mehmet Tumer and Mustafa Dolaz
Affiliation:
Keywords: Schiff base ligands, Complexes, β-blockers, Stability Constants, Potentiometric studies, Luminol chemiluminescence
Abstract: In this study, we prepared two different type complex groups. One of them is based on Schiff base (A1 , A2 and A3) Cd(II) complexes, another one is β-blockers (acebutolol (ACE), atenolol (ATE) and propranolol (PRO)) Cu(II) complexes. The ligands and their metal complexes were characterized by elemental analyses, mass spectra, 1H(13C) NMR spectra, FT-IR, UV-vis, conductivity measurements and thermal analysis studies. Protonation constants of the ligands and stability constants of their complexes were determined by potentiometric titration method at 25.00±0.02 oC under nitrogen atmosphere and ionic strength of 0.10 M sodium perchlorate. For the Schiff bases, the solvent was 50% DMSO – water; for the β-blockers, it was 50% methanol-water media. The effects of these properties on the observed inhibition of chemiluminescence and the analytical implications of the results are also discussed. Two sets of novel coordination compounds were found to inhibit the intense chemiluminescence reaction in DMSO solution between luminol and dioxygen in the presence of a strong base.
Export Options
About this article
Cite this article as:
Golcu Aysegul, Wheatley Alan R., Demirelli Havva, Tumer Mehmet and Dolaz Mustafa, Investigations into the Inhibition of Luminol Chemiluminescence by some Novel Metal Complexes, Current Analytical Chemistry 2010; 6 (2) . https://dx.doi.org/10.2174/157341110790945526
DOI https://dx.doi.org/10.2174/157341110790945526 |
Print ISSN 1573-4110 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6727 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Clinical Pharmacology of Trastuzumab
Current Clinical Pharmacology Recent Advances in Rhinovirus Therapeutics
Current Drug Targets - Infectious Disorders Fetal Protein Restriction, Taurine and Islet Plasticity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Pregnancy and Postpartum Influences on Rheumatoid Arthritis Activity:Natures Model to Investigate Systemic Biological Mechanisms in the Disease
Current Rheumatology Reviews Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies
Current Pharmaceutical Design Editorial(Thematic Issue: Hypertension and Diabetes – Update in 2013)
Current Hypertension Reviews Systemic Inflammation Induces Endothelial Dysfunction in Peritoneal Dialysis Patients
Vascular Disease Prevention (Discontinued) Diterpenes: A Therapeutic Promise for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Alkaline Starch as a New Biocompatible Base Catalyst for Improved Multi-Strategic Synthesis of Hydroquinazolinones
Current Catalysis Remediation of Cellular Hypoxic Damage by Pharmacological Agents
Current Pharmaceutical Design Mechanisms of Cardiovascular Changes in an Experimental Model of Syndrome X and Pharmacological Intervention on the Renin-Angiotensin- System
Current Vascular Pharmacology Therapeutic Potential for Thyroid Hormone Receptor-β Selective Agonists for Treating Obesity, Hyperlipidemia and Diabetes
Current Vascular Pharmacology Surgical Treatment of Neonatal Mastitis by Periareolar Drainage
Current Pediatric Reviews Bronchoscopic Appearance of Tracheal Adenoid Cystic Carcinoma
Current Respiratory Medicine Reviews Hypertension and Diabetes: Emphasis on the Renin-Angiotensin System in Atherosclerosis
Current Hypertension Reviews Editorial from Guest Editor: Current Management of Sleep Apnea and Comorbidities
Current Respiratory Medicine Reviews Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan
Current Drug Delivery Managing Comorbidity in COPD: A Difficult Task
Current Drug Targets Characteristic Imaging Features of Merkel Cell Carcinoma: A Case Report
Current Medical Imaging Noradrenaline-mediated Inhibition of Inflammatory Cytokines is Altered in Macrophages from Obese Zucker Rats: Effect of Habitual Exercise
Endocrine, Metabolic & Immune Disorders - Drug Targets